moxifloxacin has been researched along with Bacillus anthracis Infection in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demir, C; Durmuş, G; Eren, N; Karagöz, A; Kılıç, S; Yeşilyurt, M | 1 |
| Head, BM; Meyers, AF; Rubinstein, E | 1 |
| Artenstein, AW; Cristofaro, P; Delsesto, D; Kessimian, N; Lim, YP; Opal, SM; Palardy, JE; Parejo, N; Siryaporn, E | 1 |
| Brooks, TJ; Lever, MS; Sefton, AM; Simpson, AJ; Steward, J | 1 |
| Bolduc, DL; Brook, I; Camp-Hyde, TD; Elliott, TB; Foriska, MA; Germana, A; Giraldo, DE; Jackson, WE; Ledney, GD; Shoemaker, MO; Thakar, JH | 1 |
1 review(s) available for moxifloxacin and Bacillus anthracis Infection
| Article | Year |
|---|---|
Alternative pre-approved and novel therapies for the treatment of anthrax.
Topics: Alpha-Globulins; Anthrax; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Bacterial; Antitoxins; Bacillus anthracis; Bacterial Toxins; Daunorubicin; DNA Helicases; Doxorubicin; Drug Discovery; Fluoroquinolones; Humans; Interferon Inducers; Levofloxacin; Linezolid; Moxifloxacin; Ofloxacin; Polyketides; Serine Proteinase Inhibitors; Tilorone; Virulence | 2016 |
4 other study(ies) available for moxifloxacin and Bacillus anthracis Infection
| Article | Year |
|---|---|
[A severe cutaneous anthrax case complicated with sepsis in Bursa, Turkey].
Topics: Animals; Anthrax; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Debridement; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Penicillin G; Quinolines; Sepsis; Sheep; Skin Diseases, Bacterial; Turkey; Wounds and Injuries; Zoonoses | 2013 |
Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection.
Topics: Alpha-Globulins; Animals; Anthrax; Anti-Infective Agents; Aza Compounds; Bacillus anthracis; Fluoroquinolones; Humans; Liver; Male; Mice; Moxifloxacin; Quinolines; Spleen | 2011 |
Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.
Topics: Animals; Anthrax; Anti-Infective Agents; Aza Compounds; Bacillus anthracis; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Survival Analysis | 2004 |
Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Topics: Administration, Oral; Animals; Anthrax; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Blood; Ciprofloxacin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Gamma Rays; Injections, Subcutaneous; Liver; Lung; Mice; Moxifloxacin; Quinolines; Radiation Injuries, Experimental; Survival Analysis | 2005 |